Baillie Gifford & Co
INGN icon

Baillie Gifford & Co’s Inogen INGN Stock Holding History

Baillie Gifford & Co’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-141
Closed -$2.78K – 471
2022
Q4 		$2.78K Hold
141
– – ﹤0.01% 465
2022
Q3 		$3K Hold
141
– – ﹤0.01% 463
2022
Q2 		$3K Hold
141
– – ﹤0.01% 466
2022
Q1 		$5K Hold
141
– – ﹤0.01% 466
2021
Q4 		$5K Hold
141
– – ﹤0.01% 482
2021
Q3 		$6K Hold
141
– – ﹤0.01% 475
2021
Q2 		$9K Hold
141
– – ﹤0.01% 443
2021
Q1 		$7K Sell
141
-8
-5% -$399 ﹤0.01% 425
2020
Q4 		$7K Buy
+149
New +$5.14K ﹤0.01% 405

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Fred Alger Management
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Baillie Gifford & Co's INGN Position: Q1 2023 in Review

Baillie Gifford & Co sold out of Inogen (INGN) in Q1 2023, closing a stake of 141 shares — an estimated $2.78K sold.

Baillie Gifford & Co first reported a position in INGN in Q4 2020 and held it in 9 quarters. The position peaked at $9K in Q2 2021. 150 funds tracked by Wall St. Rank hold INGN as of Q1 2023.

  • Baillie Gifford & Co reported no remaining Inogen position as of Q1 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 141 Inogen shares in Q1 2023, an estimated $2.78K.
  • Baillie Gifford & Co first reported a position in Inogen in Q4 2020 and held it in 9 quarters.
  • Baillie Gifford & Co's Inogen position peaked at $9K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Inogen as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.